Miniaturization of beta-galactosidase immunoassays using chromogenic and fluorogenic substrates

Area of Science:

• Biochemistry
• Immunology
• Analytical Chemistry

Background:

• Enzyme immunoassays (EIAs) are crucial for quantifying antigens and antibodies.
• The enzyme reaction step in EIAs can utilize various substrates, including chromogenic and fluorogenic types.

Purpose of the Study:

• To compare the effectiveness of chromogenic and fluorogenic substrates in beta-galactosidase immunoassays.
• To determine the lowest detectable concentrations of human IgE using these substrates.
• To assess the potential for miniaturization of EIAs with fluorogenic substrates.

Main Methods:

• Utilized microtitration plates with anti-human IgE coating.
• Employed E. coli beta-galactosidase-labeled anti-human IgE.
• Quantified IgE using either chromogenic (o-nitrophenyl-beta-D-galactopyranoside) or fluorogenic (4-methyl-umbelliferyl-beta-D-galactopyranoside) substrates.
• Varied sample volumes from 150 microliters down to 0.3 microliters.

Main Results:

• Both chromogenic and fluorogenic substrates demonstrated comparable effectiveness in detecting low IgE concentrations (0.075-0.13 IU/ml) under optimal conditions.
• Miniaturization using fluorogenic substrates allowed quantification of progressively smaller IgE amounts as sample volumes decreased.
• Detection limits improved with miniaturization, reaching 1.5 x 10^6 molecules of IgE with 0.3 microliter samples.

Conclusions:

• Chromogenic and fluorogenic substrates are similarly effective for IgE detection in EIAs.
• Fluorogenic substrates offer significant advantages for EIA miniaturization, enabling sensitive quantification with reduced reagent volumes.
• Miniaturized EIAs using fluorogenic substrates are highly effective for detecting low analyte concentrations.